The First Genome-Wide Association Study for Type 2 Diabetes in Youth: The Progress in Diabetes Genetics in Youth (ProDiGY) Consortium

Shylaja Srinivasan, Ling Chen, Jennifer Todd, Jasmin Divers, Samuel Gidding, Steven Chernausek, Rose A Gubitosi-Klug, Megan M Kelsey, Rachana Shah, Mary Helen Black, Lynne E Wagenknecht, Alisa Manning, Jason Flannick, Giuseppina Imperatore, Josep M Mercader, Dana Dabelea, Jose C Florez, ProDiGY Consortium, Shylaja Srinivasan, Ling Chen, Jennifer Todd, Jasmin Divers, Samuel Gidding, Steven Chernausek, Rose A Gubitosi-Klug, Megan M Kelsey, Rachana Shah, Mary Helen Black, Lynne E Wagenknecht, Alisa Manning, Jason Flannick, Giuseppina Imperatore, Josep M Mercader, Dana Dabelea, Jose C Florez, ProDiGY Consortium

Abstract

The prevalence of type 2 diabetes in youth has increased substantially, yet the genetic underpinnings remain largely unexplored. To identify genetic variants predisposing to youth-onset type 2 diabetes, we formed ProDiGY, a multiethnic collaboration of three studies (TODAY, SEARCH, and T2D-GENES) with 3,006 youth case subjects with type 2 diabetes (mean age 15.1 ± 2.9 years) and 6,061 diabetes-free adult control subjects (mean age 54.2 ± 12.4 years). After stratifying by principal component-clustered ethnicity, we performed association analyses on ∼10 million imputed variants using a generalized linear mixed model incorporating a genetic relationship matrix to account for population structure and adjusting for sex. We identified seven genome-wide significant loci, including the novel locus rs10992863 in PHF2 (P = 3.2 × 10-8; odds ratio [OR] = 1.23). Known loci identified in our analysis include rs7903146 in TCF7L2 (P = 8.0 × 10-20; OR 1.58), rs72982988 near MC4R (P = 4.4 × 10-14; OR 1.53), rs200893788 in CDC123 (P = 1.1 × 10-12; OR 1.32), rs2237892 in KCNQ1 (P = 4.8 × 10-11; OR 1.59), rs937589119 in IGF2BP2 (P = 3.1 × 10-9; OR 1.34), and rs113748381 in SLC16A11 (P = 4.1 × 10-8; OR 1.04). Secondary analysis with 856 diabetes-free youth control subjects uncovered an additional locus in CPEB2 (P = 3.2 × 10-8; OR 2.1) and consistent direction of effect for diabetes risk. In conclusion, we identified both known and novel loci in the first genome-wide association study of youth-onset type 2 diabetes.

© 2021 by the American Diabetes Association.

Figures

Figure 1
Figure 1
A: QQ plot for case subjects with youth-onset T2D vs. adult control subjects without diabetes. The x-axis shows the expected distribution and the y-axis shows the observed distribution of findings. λGC = 1.08. B: QQ plot for case subjects with youth-onset T2D vs. youth control subjects without diabetes. The x-axis shows the expected distribution and the y-axis shows the observed distribution of findings. λGC = 1.09.
Figure 2
Figure 2
Manhattan plot for youth case subjects with T2D vs. adult control subjects without diabetes. The red horizontal line in the plot indicates the genome-wide significance P value threshold of 5 × 10−8. The closest genes for the seven genome-wide significant findings are shown circled in red.
Figure 3
Figure 3
Manhattan plot for youth case subjects with T2D vs. youth control subjects without diabetes. The red horizontal line in the plot indicates the genome-wide significance P value threshold of 5 × 10−8. The closest gene for the genome-wide significant finding is shown circled in red.

References

    1. International Diabetes Federation . IDF Diabetes Atlas, 8th edition, 2017. Accessed 10 November 2018. Available from
    1. Ogden CL, Carroll MD, Lawman HG, et al. . Trends in obesity prevalence among children and adolescents in the United States, 1988-1994 through 2013-2014. JAMA 2016;315:2292–2299
    1. Mayer-Davis EJ, Dabelea D, Lawrence JM. Incidence trends of type 1 and type 2 diabetes among youths, 2002-2012. N Engl J Med 2017;377:301
    1. Constantino MI, Molyneaux L, Limacher-Gisler F, et al. . Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes. Diabetes Care 2013;36:3863–3869
    1. Narasimhan S, Weinstock RS. Youth-onset type 2 diabetes mellitus: lessons learned from the TODAY study. Mayo Clin Proc 2014;89:806–816
    1. Dabelea D, Stafford JM, Mayer-Davis EJ, et al. .; SEARCH for Diabetes in Youth Research Group . Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood. JAMA 2017;317:825–835
    1. Zeitler P, Hirst K, Pyle L, et al. .; TODAY Study Group . A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 2012;366:2247–2256
    1. Langenberg C, Lotta LA. Genomic insights into the causes of type 2 diabetes. Lancet 2018;391:2463–2474
    1. Barnett AH, Eff C, Leslie RD, Pyke DA. Diabetes in identical twins. A study of 200 pairs. Diabetologia 1981;20:87–93
    1. Fuchsberger C, Flannick J, Teslovich TM, et al. . The genetic architecture of type 2 diabetes. Nature 2016;536:41–47
    1. Giannini C, Dalla Man C, Groop L, et al. . Co-occurrence of risk alleles in or near genes modulating insulin secretion predisposes obese youth to prediabetes. Diabetes Care 2014;37:475–482
    1. Dabelea D, Dolan LM, D’Agostino R Jr., et al. . Association testing of TCF7L2 polymorphisms with type 2 diabetes in multi-ethnic youth. Diabetologia 2011;54:535–539
    1. Flannick J, Mercader JM, Fuchsberger C, et al. .; Broad Genomics Platform; DiscovEHR Collaboration; CHARGE; LuCamp; ProDiGY; GoT2D; ESP; SIGMA-T2D; T2D-GENES; AMP-T2D-GENES . Exome sequencing of 20,791 cases of type 2 diabetes and 24,440 controls. Nature 2019;570:71–76
    1. Zeitler P, Epstein L, Grey M, et al. .; TODAY Study Group . Treatment options for type 2 diabetes in adolescents and youth: a study of the comparative efficacy of metformin alone or in combination with rosiglitazone or lifestyle intervention in adolescents with type 2 diabetes. Pediatr Diabetes 2007;8:74–87
    1. SEARCH Study Group . SEARCH for Diabetes in Youth: a multicenter study of the prevalence, incidence and classification of diabetes mellitus in youth. Control Clin Trials 2004;25:458–471
    1. Dabelea D, Mayer-Davis EJ, Lamichhane AP, et al. . Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study. Diabetes Care 2008;31:1422–1426
    1. Das S, Forer L, Schönherr S, et al. . Next-generation genotype imputation service and methods. Nat Genet 2016;48:1284–1287
    1. Wakefield J. A Bayesian measure of the probability of false discovery in genetic epidemiology studies. Am J Hum Genet 2007;81:208–227
    1. AMP-T2D Program, T2D-GENES Consortium. 2017. Accessed 1 December 2020. Available from
    1. Mahajan A, Taliun D, Thurner M, et al. . Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet 2018;50:1505–1513
    1. Guindo-Martinez M, Amela R, Bonàs-Guarch S, et al. . The impact of non-additive genetic associations on age-related complex disease. bioRxiv. 14 May 2020 [preprint]. DOI: 10.1101/2020.05.12.084608
    1. Lee KH, Ju UI, Song JY, Chun YS. The histone demethylase PHF2 promotes fat cell differentiation as an epigenetic activator of both C/EBPα and C/EBPδ. Mol Cells 2014;37:734–741
    1. Okuno Y, Ohtake F, Igarashi K, et al. . Epigenetic regulation of adipogenesis by PHF2 histone demethylase. Diabetes 2013;62:1426–1434
    1. Bricambert J, Alves-Guerra MC, Esteves P, et al. . The histone demethylase Phf2 acts as a molecular checkpoint to prevent NAFLD progression during obesity. Nat Commun 2018;9:2092.
    1. Williams AL, Jacobs SB, Moreno-Macías H, et al. .; SIGMA Type 2 Diabetes Consortium . Sequence variants in SLC16A11 are a common risk factor for type 2 diabetes in Mexico. Nature 2014;506:97–101
    1. AMP-T2D Program, T2D-GENES Consortium . 2017. Accessed 2 December 2020. Available from
    1. Chen HF, Hsu CM, Huang YS. CPEB2-dependent translation of long 3′-UTR Ucp1 mRNA promotes thermogenesis in brown adipose tissue. EMBO J 2018;37:37

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir